Genetics
Ancestry Matters in Multiple Sclerosis Risk Prediction: Evaluating Polygenic Risk Scores Across Diverse Populations18, Jun 2026
Topic hub
Omics Analysis
This pillar groups omics analysis posts that connect molecular measurements with disease mechanisms, biomarkers, and pathway-level interpretation.
Core Questions
Which molecular layers best explain disease biology?
How can pathway analysis turn high-dimensional results into interpretable mechanisms?
Where do omics findings suggest biomarkers or therapeutic hypotheses?
Topic Clusters
Core Articles
Genetics
Rare Immune-Regulatory Variants in Familial Multiple Sclerosis: Insights from Exome Sequencing and Molecular Modeling
17, Jun 2026This blog post discusses a recent study investigating the genetic architecture of familial multiple sclerosis through whole-exome sequencing and...
Genetics
Inflammasome Genetics and Vitamin D Status in Multiple Sclerosis: A New Immunometabolic Perspective
16, Jun 2026This blog post examines recent findings on the relationship between inflammasome-related genetic variants, vitamin D status, and multiple...
Genetics
Genetic Clues to Tumefactive Demyelination: What GWAS Reveals About a Rare Multiple Sclerosis Subtype
15, Jun 2026This blog post examines the first genome-wide association study of tumefactive demyelination, a rare and severe demyelinating disorder often...
Genetics
Mapping the Genetic Architecture of Multiple Sclerosis Through Autoimmune Disease Overlap
14, Jun 2026This blog post examines a genomic study that identified fourteen sequence variants associated with multiple sclerosis by combining large-scale...
Genetics
Mapping Multiple Sclerosis Genetics Across Ancestries: Insights from South Asian and African Populations
13, Jun 2026This blog post examines a recent genetic study investigating Multiple Sclerosis susceptibility in individuals of South Asian and African ancestry...
Genetics
Uncovering the Genetic Drivers of Relapse-Independent Progression in Multiple Sclerosis
12, Jun 2026This blog post examines recent evidence that inherited genetic burden may contribute to progression independent of relapse activity in multiple...
Genetics
Genetic Drivers of Intrathecal IgG Synthesis in Multiple Sclerosis
11, Jun 2026This blog post examines recent findings on the genetic regulation of intrathecal immunoglobulin G synthesis in multiple sclerosis. Based on a...
Genetics
Genetic Diversity in Multiple Sclerosis: What Multi-Ancestry Genomics Reveals About Disease Risk
10, Jun 2026This blog post examines a recent scientific study investigating the genetic determinants of multiple sclerosis susceptibility in people of South...
Genetics
When Multiple Sclerosis Risk Begins: Genetic and Early-Life Clues from the UK Biobank
09, Jun 2026This blog post examines a 2024 UK Biobank study showing that genetic susceptibility, sex, smoking, infectious mononucleosis, body mass index...
Genetics
Metabolomic Clues to Multiple Sclerosis: Insights from a Mendelian Randomization Study
09, Jun 2026This blog post examines a metabolome-wide Mendelian randomization study that investigates whether circulating metabolites may play causal roles in...
Genetics
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
07, Jun 2026This blog post examines the scientific challenges and future potential of predicting multiple sclerosis through genetic and environmental risk...
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Insights from UK Biobank
06, Jun 2026This blog post examines how genetic susceptibility and early-life environmental exposures may jointly shape the risk of Multiple Sclerosis (MS)....